Navigation Links
California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation
Date:9/10/2007

AB 682 (Berg, Garcia, Huffman), the California Routine HIV Screening Bill,

Cleared the Legislature Today; Bi-Partisan Bill, Sponsored by AIDS Healthcare Foundation, the California Medical Association, & the Health Officers Association of California, Will Improve Health Outcomes & Reduce

HIV Transmission

SACRAMENTO, Calif., Sept. 10 /PRNewswire/ -- AIDS Healthcare Foundation (AHF), the operator of the largest non-government HIV testing program in California, today praised the California Legislature for its passage of Assembly Bill 682, California's Routine HIV Screening Bill, which cleared the Assembly on final concurrence (64-0) today after clearing the Senate in a 38 to 1 vote late last week. The bill now moves on to the Governor's desk, where it is hoped that Governor Schwarzenegger will sign this lifesaving bill into law.

The bi-partisan bill, jointly authored by Assembly Members Patty Berg, Bonnie Garcia and Jared Huffman and co-sponsored by AIDS Healthcare Foundation, the California Medical Association (CMA) and the Health Officers Association of California, streamlines the HIV testing process, so that medical providers can identify Californians who are unaware of their HIV- positive status and bring them into care and treatment, while sustaining the fundamental voluntary nature of HIV screening. The bill removes a major barrier to HIV testing by requiring a patient to give simple consent, rather than informed consent, before an HIV test can be administered.

"AB 682 is the most important change in public HIV/AIDS policy in years," said Michael Weinstein, President of AIDS Healthcare Foundation. "This bill will initiate a cultural shift in California among providers and consumers, that, today and in the future, will ensure that thousands of Californians with HIV will get crucial and life-prolonging care and treatment."

"The California Legislature has recognized the importance of this critical
'/>"/>

SOURCE AIDS Healthcare Foundation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Senate Passes Drug-Safety Reforms to Prevent Future Vioxx-type Disasters; House Urged to Act on Strong Drug Safety Bill
2. SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193
3. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
4. PSA TestingHow Much is Too Much?
5. Hemoglobin Testing at the Point of Care
6. Testing for Human Papillomavirus
7. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
8. Rapid HIV Testing Increases Possibility of Treatment
9. Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing
10. ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic Testing of ANX-514 (Docetaxel Emulsion)
11. CytoGenix Announces Successful Testing of synDNA Vaccine for Avian Influenza Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...G, Pa., Oct. 6 /- Genaera,C...om its second Phase 1,clinical trial of trodusquem...the treatment of type 2 diabetes and obesity. MSI-...lecular target that controls the function,of both ...se and decrease,appetite. In the study, MSI-1436 w...
(Date:10/6/2008)...erence Call Scheduled for 9:00 AM ET Today -, SEA...rporation (Nasdaq:,DNDN) announced today that it h...hase 3, randomized, double-blind, placebo-controll...ma Treatment, also known as D9902B),clinical trial...,investigational active cellular immunotherapy PRO...
(Date:10/6/2008)... /- Dendreon Corporation (N...nday, October 6, 2008 at 9:00 AM,ET (6:00 AM PT) t...s IMPACT,(IMmunotherapy for Prostate AdenoCarcinom...of PROVENGE(R) (sipuleucel-T), the Company,s inves...reatment of advanced prostate,cancer., Those i...
(Date:10/5/2008)...ed in New England Journal of Medicine reaffirm,wel...e of SPIRIVA(R),HandiHaler(R), RIDGEFIELD, Conn.,...he,UPLIFT (Understanding Potential Long-term Impac... SPIRIVA(R) HandiHaler(R) (tiotropium bromide,inha...ction for up to 4,years as measured by FEV(1) (p<0...
Breaking Medicine Technology:Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6RoundTable Healthcare Partners Closes Sale of MedAssist Holding Inc to Firstsource Solutions Limited 939 1RoundTable Healthcare Partners Closes Sale of MedAssist Holding Inc to Firstsource Solutions Limited 939 2RoundTable Healthcare Partners Closes Sale of MedAssist Holding Inc to Firstsource Solutions Limited 939 3Center for Poverty Research to study senior hunger in America 2387 1Center for Poverty Research to study senior hunger in America 2387 2Connecticut Catholic Conference Wrong to Allow Plan B in Catholic Hospitals 2384 1Connecticut Catholic Conference Wrong to Allow Plan B in Catholic Hospitals 2384 2American Academy of Dermatology Association Commends President Bush for Signing Tanning Accountability and Notification 28TAN 29 Act 2380 1American Academy of Dermatology Association Commends President Bush for Signing Tanning Accountability and Notification 28TAN 29 Act 2380 2
...e/ -- A nationally renowned,cancer researcher affi...nted a novel study design concept called a Complet...e new agent development.,Studies utilizing this de...work,s innovative Translational Oncology Program (...e trials in a community,setting. These types of tr...
...nted at American Society of,Clinical Oncology (ASC...Newswire-FirstCall/ -- Medarex, Inc.,and Bristol-M...ultiple clinical studies of ipilimumab (MDX-010), ...h advanced melanoma.,The results demonstrated an a...melanoma either as a monotherapy or in combination...
Other Medicine Technology:Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 2Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 3Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 4Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 5Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 2Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 3Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 4Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 5Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 6Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 7
(Date:10/7/2008)...RNewswire-FirstCall/ -- Stallergenes S.A.,today an...greement with,Catalent for the promotion and distr...FLEX(R), co-developed and co-manufactured by Catal...sts of a syringe pre-filled with adrenaline, which....3 and 0.15 mg), in an,autoinjector device. The Me...
(Date:10/7/2008)...of asthma in a young child may well be more challe..., according to a review of research and clinical e... Indiana University School of Medicine and Riley H... issue of Clinical Pediatrics . , "Wheezing ca... Professor of Pediatrics at the IU School of Medic...
(Date:10/7/2008)...rial Specialties, Mfg. is pleased to announce the ...hese filters are exclusively available from Indust... push-to-connect style fittings integrated into th...ne filter offers versatility and customization for... (PRWEB) October 7, 2008 -- Exclusively availa...
(Date:10/6/2008)...fight against childhood obesity, researcher notes ... Three-quarters of middle schools have vending mac...new study finds. , The research demonstrates th...ls, and "that those vending machines don,t always ...y Virus, a registered dietitian with the Center fo...
Breaking Medicine News(10 mins):Health News:Stallergenes Partners With Catalent and the Medical House for Commercialization of Adrenaline Autoinjector in Europe 2Health News:Wheezing and asthma in young children 2Health News:Vending Machines Found in Most Middle Schools 2
...ol, 'in'? A new report by the American Medical As...of college girls and their wild (s) ways!// A sur...at breaking out of control and going really berser... Three out of four women seem to get drunk and use...
...he world have assembled in Glasgow and discussing ...ities. The conference reviewed methadone programme...h annual National Drug Treatment Conference. Drug ... disturbing when a11-year-old girl had admitted ta...
...ccal meningitis has claimed 21 lives and 369 other...national capital// during the past three months, t...n infection of the fluid in the spinal cord and th...brain. A full cure is possible if the disease is d...
...luenza or bird flu in Jammu and Kashmir is slowly ... start to leave for their summer// homes in Russia... Migratory Bird Reserve is located 28 km north of ... around 50,000 migratory birds there these days wa...
Other Medicine News:Health News:Meningitis Back in Delhi and 21 Dead 2Health News:Bird Flu Fears Recede As Migratory Birds Leave 2
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed.
The Neuroclip is designed for safe, quick, and stable fixation of cranial bone flaps. Application is simple with minimal instrumentation. The Neuroclip can be applied to the cranial bone flap while t
Lorenz 1.0 mm titanium system provides a rigid fixation alternative for areas with high palpability and prominent bone formation. These areas include the frontal bone and the areas surrounding the or
1.0 mm Micro System. The Titanium Micro System is also useful in the practice of ENT, Neurosurgery and Handsurgery.
Medicine Products: